Eggs, Dietary Choline, and Nonalcoholic Fatty Liver Disease in the Framingham Heart Study

被引:0
|
作者
Yiannakou, Ioanna [1 ]
Long, Michelle T. [2 ,3 ]
Jacques, Paul F. [4 ]
Beiser, Alexa [5 ,6 ]
Pickering, Richard T. [1 ]
Moore, Lynn L. [1 ]
机构
[1] Boston Univ, Chobanian & Avedisian Sch Med, Dept Med Prevent Med & Epidemiol, Boston, MA 02118 USA
[2] Boston Univ, Chobanian & Avedisian Sch Med, Dept Med, Sect Gastroenterol, Boston, MA USA
[3] Novo Nordisk, Vandtarnsvej 108-110, Soborg, Denmark
[4] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Nutr Epidemiol, Boston, MA USA
[5] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA
[6] Boston Univ, Chobanian & Avedisian Sch Med, Dept Neurol, Boston, MA USA
关键词
eggs; dietary choline; lutein; zeaxanthin; liver fat; nonalcoholic fatty liver disease; PLASMA CAROTENOID CONCENTRATIONS; FOOD-FREQUENCY QUESTIONNAIRE; CARDIOMETABOLIC RISK-FACTORS; CARDIOVASCULAR RISK; HEPATIC STEATOSIS; CONSUMPTION; METABOLISM; BETAINE; PHOSPHATIDYLCHOLINE; INFLAMMATION;
D O I
10.1016/j.tjnut.2024.10.026
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Eggs are rich in bioactive compounds, including choline and carotenoids that may benefit cardiometabolic outcomes. However, little is known about their relationship with nonalcoholic fatty liver disease (NAFLD). Objectives: We investigated the association between intakes of eggs and selected egg-rich nutrients (choline, lutein, and zeaxanthin) and NAFLD risk and changes in liver fat over similar to 6 y of follow-up in the Framingham Offspring and Third Generation cohorts. Methods: On 2 separate occasions (2002-2005 and 2008-2011), liver fat was assessed using a computed tomography scan to estimate the average liver fat attenuation relative to a control phantom to create the liver phantom ratio (LPR). In 2008-2011, cases of incident NAFLD were identified as an LPR <= 0.33 in the absence of heavy alcohol use, after excluding prevalent NAFLD (LPR <= 0.33) in 2002-2005. Food frequency questionnaires were used to estimate egg intakes (classified as <1, 1, and >= 2 per week), dietary choline (adjusted for body weight using the residual method), and the combined intakes of lutein and zeaxanthin. Multivariable modified Poisson regression and general linear models were used to compute incident risk ratios (RR) of NAFLD and adjusted mean annualized liver fat change. Results: NAFLD cumulative incidence was 19% among a total of 1414 participants. We observed no associations between egg intake or the combined intakes of lutein and zeaxanthin with an incident NAFLD risk or liver fat change. Other diet and cardiometabolic risk factors did not modify the association between egg intake and NAFLD risk. However, dietary choline intakes were inversely associated with NAFLD risk (RR for tertile 3 compared with tertile 1: 0.69, 95% CI: 0.51, 0.94). Conclusions: Although egg intake was not directly associated with NAFLD risk, eggs are a major source of dietary choline, which was strongly inversely associated with NAFLD risk in this community-based cohort.
引用
收藏
页码:923 / 935
页数:13
相关论文
共 50 条
  • [21] Innate immunity and nonalcoholic fatty liver disease
    Kountouras, Jannis
    Kazakos, Evangelos
    Kyrailidi, Foteini
    Polyzos, Stergios A.
    Zavos, Christos
    Arapoglou, Stergios
    Boziki, Marina
    Mouratidou, Maria C.
    Tzitiridou-Chatzopoulou, Maria
    Chatzopoulos, Dimitrios
    Doulberis, Michael
    Papaefthymiou, Apostolis
    Vardaka, Elisabeth
    ANNALS OF GASTROENTEROLOGY, 2023, 36 (03): : 244 - 256
  • [22] Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression
    Corbin, Karen D.
    Zeisel, Steven H.
    CURRENT OPINION IN GASTROENTEROLOGY, 2012, 28 (02) : 159 - 165
  • [23] Myosteatosis in nonalcoholic fatty liver disease: An exploratory study
    De Munck, Toon J. I.
    Verhaegh, Pauline
    Lodewick, Toine
    Bakers, Frans
    Jonkers, Daisy
    Masclee, Ad. A. M.
    Verbeek, Jef
    Koek, Ger H.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (03)
  • [24] Choline intake in a large cohort of patients with nonalcoholic fatty liver disease
    Guerrerio, Anthony L.
    Colvin, Ryan M.
    Schwartz, Amy K.
    Molleston, Jean P.
    Murray, Karen F.
    Diehl, AnnaMae
    Mohan, Parvathi
    Schwimmer, Jeffrey B.
    Lavine, Joel E.
    Torbenson, Michael S.
    Scheimann, Ann O.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2012, 95 (04) : 892 - 900
  • [25] Severity of Nonalcoholic Fatty Liver Disease on Sonography and Risk of Coronary Heart Disease
    Lee, Sun Hwa
    Yun, Seong Jong
    Kim, Dong Hyeon
    Jo, Hyeon Hwan
    Park, Yong Sung
    JOURNAL OF CLINICAL ULTRASOUND, 2017, 45 (07) : 391 - 399
  • [26] Alcoholic liver disease/nonalcoholic fatty liver disease index: distinguishing alcoholic from nonalcoholic fatty liver disease
    Cerovic, Ivana
    Mladenovic, Dusan
    Jesic, Rada
    Naumovic, Tamara
    Brankovic, Milos
    Vucevic, Danijela
    Aleksic, Vuk
    Radosavljevic, Tatjana
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (08) : 899 - 904
  • [27] Nonalcoholic fatty liver disease and the heart in children and adolescents
    Lucia Pacifico
    Claudio Chiesa
    Caterina Anania
    Antonio De Merulis
    John Frederick Osborn
    Sara Romaggioli
    Eugenio Gaudio
    World Journal of Gastroenterology, 2014, 20 (27) : 9055 - 9071
  • [28] Immunological and molecular basis of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
    Radwan, Mohamed M.
    Radwan, Basil M.
    Nandipati, Kalyana C.
    Hunter, William J., III
    Agrawal, Devendra K.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (08) : 727 - 738
  • [29] Lipid mediators of liver injury in nonalcoholic fatty liver disease
    Liangpunsakul, Suthat
    Chalasani, Naga
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2019, 316 (01): : G75 - G81
  • [30] Nonheavy Alcohol Use Associates With Liver Fibrosis and Nonalcoholic Steatohepatitis in the Framingham Heart Study
    Rice, Brooke A.
    Naimi, Timothy S.
    Long, Michelle T.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (11) : 2854 - +